ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
FRA16D |
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
|
0.656 |
0.577 |
HOXB@ |
|
homeobox B cluster
|
|
|
0.631 |
0.538 |
HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
MT1JP |
|
metallothionein 1J, pseudogene
|
|
|
0.588 |
0.731 |
NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
PTMAP4 |
|
prothymosin alpha pseudogene 4
|
|
|
0.638 |
0.731 |
PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
SNORD15A |
|
small nucleolar RNA, C/D box 15A
|
|
|
0.653 |
0.577 |
SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
SCLC1 |
|
small cell cancer of the lung
|
|
|
0.612 |
0.577 |
MLRL |
|
Myeloid leukemia-related gene (myeloid tumor suppressor)
|
|
|
0.564 |
0.769 |
TDGF1P6 |
|
teratocarcinoma-derived growth factor 1 pseudogene 6
|
|
|
0.659 |
0.577 |
SNHG1 |
|
small nucleolar RNA host gene 1
|
|
|
0.576 |
0.692 |
LINC00328 |
|
long intergenic non-protein coding RNA 328
|
|
|
0.608 |
0.692 |
TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
GAS5 |
|
growth arrest specific 5
|
|
|
0.497 |
0.808 |
SNORD35B |
|
small nucleolar RNA, C/D box 35B
|
|
|
0.653 |
0.538 |
AFAP1-AS1 |
|
AFAP1 antisense RNA 1
|
|
|
0.573 |
0.538 |